Arch Therapeutics Statistics
Total Valuation
ARTH has a market cap or net worth of $5.60 million. The enterprise value is $12.67 million.
Market Cap | 5.60M |
Enterprise Value | 12.67M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ARTH has 4.74 million shares outstanding. The number of shares has increased by 276.77% in one year.
Shares Outstanding | 4.74M |
Shares Change (YoY) | +276.77% |
Shares Change (QoQ) | +0.38% |
Owned by Insiders (%) | 25.13% |
Owned by Institutions (%) | 25.30% |
Float | 2.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.08 |
PS Ratio | 48.52 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 109.88 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
Current Ratio | 0.16 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.27 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -437.81% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $14,416 |
Profits Per Employee | -$997,077 |
Employee Count | 8 |
Asset Turnover | 0.06 |
Inventory Turnover | 0.06 |
Taxes
Income Tax | -1.38M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.67% in the last 52 weeks. The beta is 3.56, so ARTH's price volatility has been higher than the market average.
Beta (1Y) | 3.56 |
52-Week Price Change | -60.67% |
50-Day Moving Average | 1.93 |
200-Day Moving Average | 2.73 |
Relative Strength Index (RSI) | 33.77 |
Average Volume (30 Days) | 4,229 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ARTH had revenue of $115,331 and -$7.98 million in losses. Loss per share was -$3.31.
Revenue | 115,331 |
Gross Profit | 31,197 |
Operating Income | -5.26M |
Pretax Income | -7.86M |
Net Income | -7.98M |
EBITDA | -5.26M |
EBIT | -5.26M |
Loss Per Share | -$3.31 |
Balance Sheet
The company has $205,850 in cash and $7.28 million in debt, giving a net cash position of -$7.08 million or -$1.49 per share.
Cash & Cash Equivalents | 205,850 |
Total Debt | 7.28M |
Net Cash | -7.08M |
Net Cash Per Share | -$1.49 |
Equity / Book Value | -9.58M |
Book Value Per Share | -2.02 |
Working Capital | -9.58M |
Cash Flow
In the last 12 months, operating cash flow was -$3.59 million and capital expenditures -$4,521, giving a free cash flow of -$3.59 million.
Operating Cash Flow | -3.59M |
Capital Expenditures | -4,521 |
Free Cash Flow | -3.59M |
FCF Per Share | -$0.76 |
Margins
Gross margin is 27.05%, with operating and profit margins of -4,563.74% and -6,916.28%.
Gross Margin | 27.05% |
Operating Margin | -4,563.74% |
Pretax Margin | -6,819.01% |
Profit Margin | -6,916.28% |
EBITDA Margin | -4,562.05% |
EBIT Margin | -4,563.74% |
FCF Margin | -3,113.89% |
Dividends & Yields
ARTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -276.77% |
Shareholder Yield | -276.77% |
Earnings Yield | -142.54% |
FCF Yield | -64.18% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 18, 2023. It was a reverse split with a ratio of 1:200.
Last Split Date | Jan 18, 2023 |
Split Type | Reverse |
Split Ratio | 1:200 |
Scores
ARTH has an Altman Z-Score of -65.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -65.23 |
Piotroski F-Score | 3 |